title: Schistosomiasis Sustained Control Program in Ethnic Groups Around Ninefescha (Eastern Senegal).
abstract: Schistosomiasis is the second most significant parasitic disease in children in several African countries. For this purpose, the "Programme National de Lutte contre les Bilharzioses" (PNLB) was developed in partnership with the World Health Organization (WHO) to control this disease in Senegal. However, geographic isolation of Bedik ethnic groups challenged implementation of the key elements of the schistosomiasis program in eastern Senegal, and therefore, a hospital was established in Ninefescha to improve access to health care as well as laboratory support for this population. The program we have implemented from 2008 in partnership with the PNLB/WHO involved campaigns to 1) evaluate schistosomiasis prevalence in children of 53 villages around Ninefescha hospital, 2) perform a mass drug administration following the protocol established by the PNLB in school-aged children, 3) monitor annual prevalence, 4) implement health education campaigns, and 5) oversee the building of latrines. This campaign led to a drop in schistosomiasis prevalence but highlighted that sustainable schistosomiasis control by praziquantel treatment, awareness of the use of latrines, and inhabitants' voluntary commitment to the program are crucial to improve Schistosoma elimination. Moreover, this study revealed that preschool-aged children, for whom praziquantel was not recommended until 2014 in Senegal, constituted a significant reservoir for the parasite.
authors.affiliation: Université de Caen Normandie, UNICAEN, UFR des Sciences Pharmaceutiques, Laboratoire de Parasitologie et Mycologie Médicale, Caen, France. monique.ndiaye@unicaen.fr.
authors.forename: Monique
authors.initials: M
authors.lastname: N'Diaye
authors.affiliation: Centre de Santé, Kedougou, Senegal.
authors.forename: Elhadji M
authors.initials: EM
authors.lastname: Dioukhane
authors.affiliation: Ninefescha Hospital, Ninefescha, Senegal.
authors.forename: Babacar
authors.initials: B
authors.lastname: Ndao
authors.affiliation: Programme National de Lutte contre les Bilharzioses/World Health Organization Neglected Tropical Diseases, Dakar, Senegal.
authors.forename: Kemo
authors.initials: K
authors.lastname: Diedhiou
authors.affiliation: Inter-country Support Team for West Africa, World Health Organization Neglected Tropical Diseases, Ouagadougou, Burkina Faso.
authors.forename: Lamine
authors.initials: L
authors.lastname: Diawara
authors.affiliation: Programme National de Lutte contre les Bilharzioses/World Health Organization Neglected Tropical Diseases, Dakar, Senegal.
authors.forename: Idrissa
authors.initials: I
authors.lastname: Talla
authors.affiliation: Université de Caen Normandie, UNICAEN, UFR des Sciences Pharmaceutiques, Laboratoire de Parasitologie et Mycologie Médicale, Caen, France.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Vernet
authors.affiliation: Université de Caen Normandie, UNICAEN, UFR des Sciences Pharmaceutiques, Laboratoire de Parasitologie et Mycologie Médicale, Caen, France.
authors.forename: François
authors.initials: F
authors.lastname: Bessin
authors.affiliation: Université de Caen Normandie, UNICAEN, UFR des Sciences Pharmaceutiques, Laboratoire de Parasitologie et Mycologie Médicale, Caen, France.
authors.forename: Dominique
authors.initials: D
authors.lastname: Barbier
authors.affiliation: Le Kaïcedrat Association, Paris, France.
authors.forename: Patrick
authors.initials: P
authors.lastname: Dewavrin
authors.affiliation: Ecole du Val-de-Grâce, Paris, France.
authors.forename: Francis
authors.initials: F
authors.lastname: Klotz
authors.affiliation: Université de Caen Normandie, UNICAEN, UFR des Sciences Pharmaceutiques, Laboratoire de Parasitologie et Mycologie Médicale, Caen, France.
authors.forename: Pierre
authors.initials: P
authors.lastname: Georges
mesh_terms: D000293:Adolescent; D000818:Animals; D002648:Child; D002675:Child, Preschool; D005006:Ethnicity / Q000706:statistics & numerical data; D006266:Health Education; D006293:Health Promotion; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011223:Praziquantel / Q000627:therapeutic use; D015995:Prevalence; D012548:Schistosoma haematobium; D012550:Schistosoma mansoni; D012552:Schistosomiasis / Q000453:epidemiology / Q000517:prevention & control*; D012553:Schistosomiasis haematobia / Q000453:epidemiology / Q000517:prevention & control; D012555:Schistosomiasis mansoni / Q000453:epidemiology / Q000517:prevention & control; D012556:Schistosomicides / Q000627:therapeutic use; D012675:Senegal / Q000453:epidemiology
chemical_list: D012556:Schistosomicides; D011223:Praziquantel